JWJie Wang

Jie Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jie Wang has a total of 6 co-authors. Here are the top co-authors by number of shared publications:

  • Lei Xia

    Department of Orthopaedic Surgery, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, P. R. China

    2 shared publications
  • Yonggang Fan

    Department of Orthopaedic Surgery, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, People’s Republic of China

    2 shared publications
  • Hongmou Zhao

    Foot and Ankle Surgery Department, Honghui Hospital, Xi’an Jiaotong University, Xi’an, People’s Republic of China

    1 shared publication
  • Mandi Cai

    Institute of Spinal Deformity, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, P. R. China

    1 shared publication
  • Wu Hu

    Department of Foot and Ankle Surgery, Honghui Hospital, Xi’an Jiaotong University, Xi’an 710054, China

    1 shared publication
  • Yinan Jin

    Department of Foot and Ankle Surgery, Honghui Hospital, Xi’an Jiaotong University, Xi’an 710054, China

    1 shared publication

Latest Publications

  • Open Access

    Advances and Application Potential of Functional and Stimuli-Responsive Hydrogels in Diabetic Bone Repair

    by Yinan Jin, Jie Wang, Wu Hu, Hongmou Zhao

    Impaired bone healing in diabetes continues to present a major challenge in orthopedic and regenerative medicine. The compromised osseous regeneration typically stems from a complex pathological cascade—namely, persistent local hyperglycemia, excessive reactive oxygen species (ROS), impaired neurovascular coupling, sustained low-grade inflammation, altered insulin signaling, and the deleterious deposition of advanced glycation end products. Together, these systemic and microenvironmental anomalies impede endogenous repair, potentially culminating in delayed union or frank non-union. To overcome these limitations, functional and stimuli-responsive (smart) hydrogel networks have emerged as a versatile therapeutic platform. These matrices provide sustained local delivery, while selected responsive chemistries couple release or degradation to glucose, ROS, proteases, pH, or externally applied light. Temperature-dependent gelation, antioxidant activity, and electrical conductivity are distinguished from pathological-signal-triggered release. In this review, we summarize current progress in the rational design and implementation of functional and stimuli-responsive hydrogels for diabetic bone repair. We evaluate their biological mechanisms together with responsive chemistry, tested trigger levels, release and degradation kinetics, mechanical properties, and the relevance of each experimental model, concluding with prospective strategies to guide subsequent biomaterial innovation and clinical translation in this domain.

  • Open Access

    Lung Metastasis Probability in Ewing Sarcoma: A Nomogram Based on the SEER Database

    by Jie Wang, Yonggang Fan, Lei Xia

    Background. Up to now, an accurate nomogram to predict the lung metastasis probability in Ewing sarcoma (ES) at initial diagnosis is lacking. Our objective was to construct and validate a nomogram for the prediction of lung metastasis in ES patients. Methods. A total of 1157 patients with ES from the Surveillance, Epidemiology, and End Results (SEER) database were retrospectively collected. The predictors of lung metastasis were identified via the least absolute shrinkage and selection operator (LASSO) and multivariate logistic analysis. The discrimination and calibration of the nomogram were validated by receiver operating characteristic (ROC) curve and calibration curve. Decision curve analysis (DCA) was used to evaluate the clinical usefulness and net benefits of the prediction model. Results. Factors including age, tumor size, primary site, tumor extension, and other site metastasis were identified as the ultimate predictors for the nomogram. The calibration curves for the training and validation cohorts both revealed good agreement, and the Hosmer–Lemeshow test identified that the model was well fitted (p > 0.05). In addition, the area under the ROC curve (AUC) values in the training and validation cohorts were 0.732 (95% confidence interval, CI: 0.607–0.808) and 0.741 (95% CI: 0.602–0.856), respectively, indicating good predictive discrimination. The DCA showed that when the predictive metastasis probability was between 1% and 90%, the nomogram could provide clinical usefulness and net benefit. Conclusion. The nomogram constructed and validated by us could provide a convenient and effective tool for clinicians that can improve prediction of the probability of lung metastasis in patients with ES at initial diagnosis.